Recent Material Events - Hana Biosciences, Inc (HNAB)

Filing Date	Description
2008-09-10	On September 9, 2008, Hana Biosciences, Inc. (the “Company”) issued a press release announcing that the pre-specified response criteria necessary to proceed to full enrollment of 56 patients in its rALLy trial of Marqibo has been sati ...
2008-06-13	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. ...
2008-06-11	On June 6, 2008, Hana Biosciences, Inc. (the “Company”) entered into a new employment agreement (the “Agreement”) with Steven R. Deitcher, the Company’s President and Chief Executive Officer. ...
2008-06-04	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. ...
2008-05-27	On May 20, 2008, Hana Biosciences, Inc. (the “Company”) received notification from the NASDAQ Listings Qualification Department that the Company’s stockholders’ equity of $7,251,251, as reported in the Company’s Quart ...
2008-03-19	Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ...
2008-03-06	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. ...
2008-01-25	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ...
2007-03-01	Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.... ...
2007-02-20	On February 20, 2007, Hana Biosciences, Inc. (the “Company”) issued a press release announcing the status of its development of its product candidate Zensana TM (ondansetron HCI) Oral Spray. The press release is attached to this Curr... ...